Home » J&J Closer to Emerging $20 Billion Blood-Thinner Market
J&J Closer to Emerging $20 Billion Blood-Thinner Market
Johnson & Johnson (J&J) is making headway in the development of a new, potentially lucrative anti-clotting drug.
TheStreet
TheStreet
Upcoming Events
-
07May
-
14May
-
30May